Disease

Salivary Gland Tumors Diagnosis and Treatment

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · JOURNAL ARTICLE

Tumor genomic alterations and their exploratory association with treatment response in recurrent head and neck cancer patients

Scientific Reports

Single-center retrospective analysis of 86 patients with exploratory, hypothesis-generating associations between genomic alterations and clinical outcomes; the authors explicitly state prospective validation in larger cohorts is necessary before clinical application.

PreliminaryDaria A. Gaykalova Salivary Gland Tumors Diagnosis and Treatment Andrey Loginov

Reported

TP53 mutation prevalence55%

TP53 and OS hazard ratio1.77

TP53 and OS p-value0.033

AUG 17, 2026 · JOURNAL ARTICLE

Management of Malignant Salivary Gland Tumors: A 20‐Year SEER Database Analysis

Otolaryngology

A large retrospective population database analysis confirming established surgical primacy in salivary gland cancer management, with descriptive trend data on evolving multimodal approaches but no comparative effectiveness or hard clinical outcomes.

Important Confirmatory EvidenceK. Robert McIntire Salivary Gland Tumors Diagnosis and Treatment JB Eyring

Reported

Sample size24029

Surgery alone proportion36.3%

Surgery with adjuvant radiation p…36.5%